Adalimumab for non-infectious uveitis: is it cost-effective? | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Adalimumab for non-infectious uveitis: is it cost-effective?

Online download statistics by month:

Online download statistics by month: February 2019 to July 2022

	Abstract	Full	Pdf
Feb 2019	1215	35	28
Mar 2019	1211	15	8
Apr 2019	961	3	3
May 2019	924	8	7
Jun 2019	512	13	2
Jul 2019	451	12	3
Aug 2019	663	9	4
Sep 2019	639	10	2
Oct 2019	413	39	24
Nov 2019	257	46	27
Dec 2019	146	37	8
Jan 2020	80	26	7
Feb 2020	101	19	5
Mar 2020	81	29	4
Apr 2020	63	29	4
May 2020	103	34	5
Jun 2020	113	23	1
Jul 2020	64	20	2
Aug 2020	117	17	5
Sep 2020	144	29	6
Oct 2020	66	18	1
Nov 2020	88	1	2
Dec 2020	104	2	0
Jan 2021	72	5	5
Feb 2021	85	0	2
Mar 2021	90	5	4
Apr 2021	52	0	0
May 2021	15	4	5
Jun 2021	3	3	2
Jul 2021	7	6	4
Aug 2021	5	3	3
Sep 2021	1	1	3
Oct 2021	68	5	4
Nov 2021	75	4	1
Dec 2021	75	3	3
Jan 2022	34	4	1
Feb 2022	31	3	0
Mar 2022	48	7	2
Apr 2022	60	0	0
May 2022	57	1	2
Jun 2022	107	5	1
Jul 2022	85	4	2
Total	9486	537	202